NYSE:CRLLife Sciences
Charles River Laboratories International (CRL) On Lilly TuneLab Deal And The Valuation Debate
AI partnership with Lilly TuneLab puts Charles River Laboratories International stock in focus
Charles River Laboratories International (CRL) has drawn fresh attention after announcing a collaboration with Lilly TuneLab, an AI and machine learning drug discovery platform created by Eli Lilly and Company.
The agreement positions Charles River to supply nonclinical testing services to TuneLab participants, standardizing protocols across the platform and supporting AI models that aim to...

